A Delicate Balance of Innovation and Access: The Future of Gene Patenting After Association for Molecular Pathology v. Myriad Genetics, Inc
A Roundtable discussion hosted by the Center for Law and Biomedical Sciences and the Health Law Section of the Utah State Bar
November 1st: 12:15-3:00
The University of Utah S.J. Quinney College of Law’s Center for Law and Biomedical Sciences focuses on new developments in the biosciences, including genetics and personalized medicine, biomedical informatics, cognitive sciences, and neuroscience. On November 1 from 12:15 — 3:00 p.m., the Center, along with the Health Law Section of the Utah State Bar, hosted a roundtable at the College of Law titled “A Delicate Balance of Innovation and Access: The Future of Gene Patenting after Association for Molecular Pathology, et al. v. Myriad Genetics, Inc. et al.”, a case that invalidated some but not all of the patents on two genes implicated in breast cancer. In the video interview, Professors Kenneth Chahine and Amelia Rinehart, and Leslie Francis, the Center’s Director, discuss the upcoming program, which also includes participants D. Brian Dawson, Benjamin Jackson, Wendy Kohlmann, Elaine Lyon, John Mejia.